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Spectroscopic data for new compound v4 isolated from A. viridis. 
(3S)-1,7-di(4-hydroxyphenyl)-heptan-3-O-α-L-arabinofuranosyl(1→6)-β-D-
glucopyranoside (v4): brown amorphous solid; [α]
D
22 -51.0 (c 0.1, MeOH); UV (MeOH) 
λmax (log ε) 224 (3.83), 278 (3.55) nm; IR (MeOH) νmax 3357, 2929, 1614, 1513, 1450, 






C-NMR data, see Table S1; HR-ESI-MS 
m/z 593,2617 [M - H]
-
 (calcd. for C30H42O12-H, 593.2604). 
Experimental procedure for isolation and structure elucidation. Optical rotations 
were measured on a Rudolph Research Analytical AUTOPOL IV automatic polarimeter. 
UV spectra were recorded using GBC Cintra 40 UV/VIS spectrometer. IR spectra were 
recorded at a ThermoScientific Nicolet 6700 FT-IR spectrometer using capilar film 




C, HSQC, HMBC) were recorded on a Bruker Avance 
III 500 spectrometer at 500.26 for 
1
H and 125.80 MHz for 
13
C, with CD3OD as solvent 
and TMS as reference. Mass spectral (HR-ESI-MS) data were obtained from Agilent 
Technologies 6210 time-of-flight LC/MS system. For column chromatography (CC) 
silicagel 60 (SiO2; under 0.063 mm, Merck) was used. Analytical TLC was carried out on 
silicagel 60 GF254 20 × 20 cm plates, layer thickness 0.25 mm (Merck). Semipreparative 
HPLC was performed on an Agilent 1100 Series instrument equipped with DAD and 
using a Zorbax Eclipse XDB C-18 column (250 mm × 9.4 mm, 5 µm). All solvents used 
for column chromatography were freshly distilled and solvents for HPLC analysis were 
chromatographic grade. 
Plant Material. The plant material was collected at Stara planina in south-eastern 
Serbia in July 2010 and was identified by Professor Petar Marin, Faculty of Biology, 
University of Belgrade, Serbia. A voucher specimen No. 16681 was deposited at the 
Herbarium of the Institute of Botany and Botanical Garden ’Jevremovac’, Faculty of 
Biology, University of Belgrade (BEOU), Serbia. 
Extraction and isolation. The air-dried bark (150.0 g) was powdered and 
extracted with CHCl3/MeOH 1:1 (4 × 1 l, 24 h) at room temperature, with the use of an 
ultrasonic bath in the last hour of extraction. The yield of the extraction was 22 %. The 
half of the crude extract (16.5 g) was fractionated by gradient CC (60 cm length and 5 cm 
diameter column size), starting elution with 100% CH2Cl2 and gradually increasing 
polarity by addition of MeOH (up to 40% MeOH) to yield 200 fractions of approximately 
15 ml. Similar fractions were combined after TLC (carried out with different 
CH2Cl2/MeOH solvent systems) and further fractionated by semipreparative HPLC-DAD 
into pure compounds using 0.025% HCOOH/MeCN elution system with flow rate of 4 
ml/min and gradient program: 0-20 min, 15-25% MeCN; 20-25 min, 25-40% MeCN; 25-








Figure S1. Chemical structures of compounds 4v  and 7v from A. viridis. 
 
 
 Figure S2. Heptane parts of the 
13






 Figure S3. Aromatic parts of the 
13
















Figure S4. Heptane parts of the 
13
C NMR spectra (pyridine-d5) of 4v (up) and 7v (down) 







H NMR data (CD3OD) for 4v and 7v. 
C/H 
4v 7v 
δC, tip δH (J u Hz) δC, tip δH (J u Hz) 
1 31,5; CH2 2,61 m 31,9; CH2 2,60 m 
2 37,6; CH2 1,77 m 38,3; CH2 1,75 m 
3 80,4; CH 3,67 t (6,0) 80,2; CH 3,66 m 
4 36,0; CH2
 1,59 m 35,1; CH2
 1,55 m; 1,61 m 
5 26,0; CH2 1,40 m 25,8; CH2 1,39 m 
6 33,1; CH2 1,59 m 33,2; CH2 1,54 m 
7 36,1; CH2 2,51 t (7,0) 36,1; CH2 2,50 t (7,5) 
1' 135,1; C - 135,0; C - 
2' 130,5; CH 7,02 d (8,5) 130,6; CH 7,02 d (8,5) 
3' 116,2; CH 6,68 d (8,5) 116,2; CH 6,69 d (8,5) 
4' 156,4; C - 156,3; C - 
5' 116,2; CH 6,68 d (8,5) 116,2; CH 6,69 d (8,5) 
6' 130,5; CH 7,01 d (8,5) 130,6; CH 7,02 d (8,5) 
1" 134,9; C - 135,0; C - 
2" 130,5; CH 7,01 d (8,5) 130,4; CH 6,97 d (8,5) 
3" 116,2; CH 6,68 d (8,5) 116,2; CH 6,68 d (8,5) 
4" 156,3; C - 156,3; C - 
5" 116,2; CH 6,68 d (8,5) 116,2; CH 6,68 d (8,5) 
6" 130,5; CH 6,99 d (8,5) 130,4; CH 6,97 d (8,5) 
Glcp   
1g 103,9; CH 4,29 d (8,0) 103,7; CH 4,29 d (8,0) 
2g 75,5; CH 3,18 dd (8,0; 1,5) 75,4; CH 3,18 dd (8,0; 1,5) 
3g 78,3; CH 3,34 m 78,2; CH 3,34 m 
4g 72,3; CH 3,34 m 72,1; CH 3,34 m 
5g 76,6; CH 3,36 m 76,6; CH 3,39 m 




3,64 dd (11,0; 5,5) 
4,03 dd (11,0; 2,0) 
Arabf 
  
1a 110,0; CH 4,96 d (1,0) 110,0; CH 4,97 d (1,0) 
2a 83,2; CH 4,00 m 83,2; CH 4,01 dd (3,5; 1,5) 
3a 79,1; CH 3,84 m 79,0; CH 3,84 dd (5,5; 3,5) 
4a 86,2; CH 3,96 m 86,1; CH 3,96 m 
5a 63,1; CH2 
3,58 m 
3,72 dd (12,0; 3,5) 
63,0; CH2 
3,59 dd (12,0; 5,5) 
3,69 dd (12,0; 3,5) 
 







Table S2. Statistical analysis of growth inhibition activity of A. viridis and A. glutinosa 













 1v 2v 3v 4v 5v 6v 7v 8v 9v 3g 5g 8g 9g 
1v / **** **** **** **** **** **** **** **** **** **** **** **** 
2v **** / **** **** **** **** * **** **** **** **** **** **** 
3v **** **** / **** ns **** **** ns ns ns ns ns ns 
4v **** **** **** / **** **** **** **** **** **** **** **** **** 
5v **** **** ns **** / **** **** * ns ns * ns ns 
6v **** **** **** **** **** / **** **** **** **** **** **** **** 
7v **** * **** **** **** **** / **** **** **** **** **** **** 
8v **** **** ns **** * **** **** / **** ns ns ns ns 
9v **** **** ns **** ns **** **** **** / ns *** ** ns 
3g **** **** ns **** ns **** **** ns ns / ns ns ns 
5g **** **** ns **** * **** **** ns *** ns / ns ns 
8g **** **** ns **** ns **** **** ns ** ns ns / ns 
9g **** **** ns **** ns **** **** ns ns ns ns ns / 
HaCaT 
 1v 2v 3v 4v 5v 6v 7v 8v 9v 3g 5g 8g 9g 
1v / ns **** ns **** **** **** **** **** **** *** **** **** 
2v ns / **** ns **** ns ** **** **** **** ns **** **** 
3v **** **** / **** ns **** **** **** ns **** **** ns **** 
4v ns ns **** / **** ** *** **** **** **** ns **** **** 
5v **** **** ns **** / **** **** **** ns *** **** ns **** 
6v **** ns **** ** **** / ns **** **** **** ns **** **** 
7v **** ** **** *** **** ns / **** **** **** ns **** **** 
8v **** **** **** **** **** **** **** / **** ns **** **** ns 
9v **** **** ns **** ns **** **** **** / *** **** ns **** 
3g **** **** **** **** *** **** **** ns *** / **** *** ns 
5g *** ns **** ns **** ns ns **** **** **** / **** **** 
8g **** **** ns **** ns **** **** **** ns *** **** / **** 
9g **** **** **** **** **** **** **** ns **** ns **** **** / 
  
Table S3. Statistical analysis of cell death inducing activity of A. viridis and A. glutinosa 





















  5v 15 M 5v 45 M 5g 15 M 5g 45 M 9v 15 M 9v 45 M 9g 15 M 9g 45 M 
viable cells 
untreated 
ns **** ns **** * **** ns **** 
early apoptosis ns ** ns ns ns ns ns *** 
late apoptosis ns ns ns * ns **** ns ** 
necrosis ns ns ns * ns ns ns * 
HaCaT 
  5v 15 M 5v 45 M 5g 15 M 5g 45 M 9v 15 M 9v 45 M 9g 15 M 9g 45 M 
viable cells 
untreated  
*** **** ns ** **** **** ns **** 
early apoptosis ns ns ns ns ns ns ns ns 
late apoptosis ns **** ns ns * **** ns **** 
necrosis ns **** ns ns ns * ns *** 
  
Table S4. Statistical analysis of cell cycle arresting activity of A. viridis and A. glutinosa 











  5v 15 M 5v 45 M 5g 15 M 5g 45 M 9v 15 M 9v 45 M 9g 15 M 9g 45 M 
subG0 
untreated 
ns ** ns ns * * ns ns 
G0/G1 ns **** ns ns *** **** ns ns 
S ns ns ns ns ns ns ns ns 
G2/M ns ns ns ns ns ns ns ns 
HaCaT 
  5v 15 M 5v 45 M 5g 15 M 5g 45 M 9v 15 M 9v 45 M 9g 15 M 9g 45 M 
subG0 
untreated  
* * ns ns ns ns ns ns 
G0/G1 ns ** ns ns ** * ns ** 
S ns ns ns ns ns ns ns ns 
G2/M * ns ns ns ns ns ns ns 
